TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Vistin Pharma AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
270,182
|
288,679
|
203,226 |
| Financial expenses |
9,933
|
22,533
|
7,968 |
| Earnings before taxes |
53,511
|
41,336
|
-2,568 |
| Total assets |
236,773
|
262,018
|
285,767 |
| Current assets |
84,527
|
107,852
|
111,439 |
| Current liabilities |
122,837
|
147,091
|
197,178 |
| Equity capital |
109,778
|
70,579
|
38,274 |
| - share capital |
63
|
66
|
71 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
46.4%
|
26.9%
|
13.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
19.8%
|
14.3%
|
-1.3% |
| Return on assets (ROA) |
26.8%
|
24.4%
|
1.9% |
| Current ratio |
68.8%
|
73.3%
|
56.5% |
| Return on equity (ROE) |
48.7%
|
58.6%
|
-6.7% |
| Change turnover |
-4,005
|
97,941
|
8,381 |
| Change turnover % |
-1%
|
51%
|
4% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.